Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1701 results
Lung cancer cells

We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges. We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges.

by Katie Roberts | Analysis | 14 October 2020

14 October 2020

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.  Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

by Cancer Research UK | News | 12 October 2020

12 October 2020

HPV vaccine

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

by Cancer Research UK | News | 1 October 2020

1 October 2020

Understanding why children get cancer is a huge task and extremely complex. In our latest Science Surgery, we spoke with Dr Francis Mussai about the differences between children and adult’s cancers. Understanding why children get cancer is a huge task and extremely complex. In our latest Science Surgery, we spoke with Dr Francis Mussai about the differences between children and adult’s cancers.

by Sheona Scales | Analysis | 28 September 2020

28 September 2020

This entry is part 22 of 23 in the series Science Surgery
Iain Foulkes, our executive director of research at Cancer Research UK

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding. Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

by Iain Foulkes | Opinion | 24 September 2020

24 September 2020

antibody crystal structure

Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2. Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2.

by Cancer Research UK | News | 3 September 2020

3 September 2020

We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored. We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored.

by Lilly Matson | Analysis | 2 September 2020

2 September 2020